Navigation Links
Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results
Date:11/13/2008

illion or the alternative requirement of $2.5 million in stockholders' equity in order to remain listed.

Conference Call and Webcast Information

Memory Pharmaceuticals will hold a conference call on November 13, 2008, at 9:00 a.m. EST to discuss the Company's third quarter 2008 financial results. The conference call will also be broadcast live from the "Investors" section of the Company's website. Memory Pharmaceuticals' senior management will host the conference call. Investors and other interested parties may access the call as follows:

Date: Thursday, November 13, 2008

Time: 9:00 a.m. EST

Telephone (U.S.): 866. 543.6407

Telephone (international): 617.213. 8898

Participant Passcode: 22960486

Webcast: http://www.memorypharma.com under the

"Investors" section

An audio replay of the conference call will be available from 11:00 a.m. EST on Thursday, November 13, 2008, until Thursday, November 20, 2008. To access the replay, please dial 888.286.8010 (U.S.) or 617.801.6888 (international) and enter pass code number 92102882. An audio replay of the conference call will also be available under the "Investors" section of the Company's website during the same period.

About the Company

Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders, many of which exhibit significant impairment of memory and other cognitive functions, including Alzheimer's disease and schizophrenia. For additional information, please visit our website at http://www.memorypharma.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meani
'/>"/>

SOURCE Memory Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Miniaturizing memory: Taking data storage to the molecular level
2. Memory Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
3. Memory Pharmaceuticals Granted Extension to Comply with NASDAQ Listing Requirements
4. Memory Pharmaceuticals Provides Update on NASDAQ Listing Status
5. Memoirs of a qubit: Hybrid memory solves key problem for quantum computing
6. Blanchette Rockefeller Neurosciences Institute Hosts First-Ever International Forum on Memory and Memory Disorders and Dedicates New $30 Million Research Facility
7. Jellyfish Protein Shows Potential to Help With Memory
8. Memory Pharmaceuticals Completes Phase 1 Multiple Ascending Dose Study of R4996/MEM 63908
9. SAFC Hitech(TM) Successfully Demonstrates Device-Quality GST Precursors For Phase Change Memory Applications
10. Memory Pharmaceuticals Closes Final Tranche of Equity Financing with The Stanley Medical Research Institute
11. Memory Pharmaceuticals to Announce Second Quarter 2008 Results on Wednesday, August 13, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... PRC Clinical, a full-service, ... Bay Area, will exhibit and present at the ... on March 25th and 26th in Tel Aviv, Israel. ... Israeli life science companies seeking to conduct U.S. Food ... span all phases of human trials, from Phase I ...
(Date:3/4/2015)... March 4, 2015  BioClinica®, Inc., a ... provider, today announced that clinical trial professionals ... at its annual European User Conference in ... discuss the use of its eClinical technologies ... technologies include: the Microsoft Office-Smart OnPoint CTMS; ...
(Date:3/4/2015)... , March 4, 2015 ... Paris in December 2011, ,SARAH, ... yttrium-90 resin microspheres versus sorafenib in advanced hepatocellular carcinoma ... late 2016.   SARAH, a large French ... (hepatocellular carcinoma, or HCC) has completed patient enrolment, exceeding ...
(Date:3/3/2015)... March 3, 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: ... and molecular diagnostics that target the underlying mechanisms of ... seventh-month period ended December 31, 2014. Effective ... end from May 31 to December 31. As a ... today are for the quarter and the seven months ...
Breaking Biology Technology:PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 2PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 3PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 4BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 2Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 4Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12
... has discovered and characterized a promising chemically modified Vitamin ... In animal studies, 2MD increases bone growth while leaving ... times the level of other compounds. , ,According to ... levels in the blood. Too little calcium can cause ...
... MADISON - A veteran television reporter recently asked me to ... expect to find jobs after they complete their education. The ... know, I would invest every penny I have in those ... Labor Day passes in Wisconsin, the question about jobs for ...
... MADISON, WI - The U.S. Department of Health and ... Regional Centers of Excellence (RCE) for Biodefense and Emerging ... with 11 other Midwestern institutions to form the Midwestern ... The Midwestern center, based at the University of Chicago ...
Cached Biology Technology:Biotech Pioneer Discusses Breakthrough in Osteoporosis Treatment 2Heres how todays Wisconsin children will find jobs tomorrow 2Heres how todays Wisconsin children will find jobs tomorrow 3UW-Madison Gets Federal Biodefense Funds 2
(Date:3/2/2015)... 2015 Synaptics Inc. (NASDAQ: ... solutions, today announced a new implementation of its ... rapid and secure transactions and reliable identification for ... a turnkey solution providing mouse and keyboard peripheral ... fingerprint ID solutions into their product offerings, bringing ...
(Date:2/25/2015)... Ark. , Feb. 25, 2015  ABC ... and billing in the Health and Fitness Industry, ... well as to MYiCLUBonline.  The latest upgrade includes ... the inclusion of cardless check-in via Identity One ... the first time through interactive displays at the ...
(Date:2/24/2015)... 24, 2015 Research and Markets ... the "Global 2D Gesture Recognition Market 2015-2019" ... The analysts forecast the Global 2D Gesture Recognition ... over the period 2014-2019 The increased ... is one of the major trends in the ...
Breaking Biology News(10 mins):Synaptics Unveils New Fingerprint ID Solution for Gamers 2Synaptics Unveils New Fingerprint ID Solution for Gamers 3ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2
... Researchers at the Johns Hopkins University School of Medicine ... human brain cancer cells using nanoparticles that can be ... to use. The shelf-stable particles may obviate the need ... safety concerns. The report appears in the August issue ...
... study of over 50 000 pregnancies revealed that women ... gave birth to babies with a similar birthweight to ... Nick Macklon, from the Department of Obstetrics and Gynaecology, ... the European Society of Human Reproduction and Embryology today ...
... the University of Maryland School of Medicine have found ... eats plant material cellulose at temperatures near ... the microbe,s cellulose-digesting enzyme, called a cellulase, is most ... Fahrenheit), significantly above the 100oC (212oF) boiling point of ...
Cached Biology News:Just add water and treat brain cancer 2Giving up smoking averts the adverse birth outcomes associated with tobacco 2Hot springs microbe yields record-breaking, heat-tolerant enzyme 2Hot springs microbe yields record-breaking, heat-tolerant enzyme 3
...
... miRCURY LNA technology enables sensitive and specific ... miRCURY LNA Detection probes have high binding ... sensitive detection of miRNAs. Due to the ... probes less than 1/10 the amount of ...
... Roches RTS AviTag E. coli Biotinylation Kit, ... RTS 100 E. coli expression kits. (Cat. No. ... provides reagents to rapidly generate linear expression constructs ... expression based on a combination of T7 RNA ...
... Competitor Assay Kits are ideal for studying ... PolarScreen GR Competitor Assay Kits contain partially ... one of the following proprietary fluorescent glucocorticoid ... Red (red assay kit), or GS Far ...
Biology Products: